drug discovery
The company unveiled TxGemma, a collection of Gemma-based open models aimed at improving the efficiency of AI-powered drug discovery, during its recent Check Up event.
The company, in partnership with Microsoft, aims to develop cancer medicines, followed by treatments for autoimmune diseases and rare conditions.